REFERENCIAS

1 Veasy LG, Wiedmeier SE, Orsomond GS. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987;316:421-427.

2 Hosier DM, Craenen JM, Teske DW, Wheller JJ. Resurgence of acute rheumatic fever. Am J Dis Child 1987;141:730-733.

3 Zangwill KM, Wald ER, Londino AV. Acute rheumatic fever in western Pennsylvania: persistent problem in the 1990s. J Pediatr 1991;118:561-563.

4 Taubert K A, Rowley AH, Shulman ST. Seven year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994;13:704-708.

5 Kaplan E L. Global assesment of rheumatic fever and rheumatic heart disease at the close of the century. Circulation 1993;88:1964-1972.

6 Dajani A S, Taubert K, Ferrieri P. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals. Pediatrics 1995; 96: 758-764.

7 Dajani A S, Bisno AL, Chung K J. Prevention of rheumatic fever. A statement of Health Professionals by the Committee of Rheumatic fever, Endocarditis, and Kawasaki disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation 1988:78:1082-1086.

8 Loredo-Abdalá A. Fiebre reumá tica. En Loredo-Abdalá A, ed. Medicina Interna Pediátrica.3a ed. México: Interamericana-McGraw Hill, 1996.

9 Karademir S, Demirceken F, Atalay S. Acute rheumatic fever in children in the Ankara area in 1990 -1992 and comparison with a previous study in 1980 -1989. Acta Pediatr 1994;83:882 -335.

10 Martin DR, Voss LM, Walker SJ. Acute rheumatic fever in Auxland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J 1994;13:264-268.

11 Gordis L. Studies in the epidemiology and preventability of rheumatic fever. I. Demographic factors and incidence of acute attacks. J Chron Dis 1969;21:645-654.

12 Stollerman G. Epidemiology of rheumatic fever. En: Rheumatic fever and streptococcal infections. New York: Grune and Stratton, 1975:92.

13 Wilson MG Schweitzer M. Pattern of hereditary susceptibility in rheumatic fever. Circulation 1954;10:699.

14 DiSciascio G, Taranta A. Rheumatic fever in children. Am Heart J 1980; 99:635.

15 Loredo-Abdalá A, Sandoval GR, Lastra EL. Comportamiento clínico de 200 casos de fiebre reumática. Acta Pediatr Mex 1976;1:83-89.

16 Glyn LE, Holborow EJ. Bood groups and their secretion in rheumatic fever. Rheumatology 1969;2:113.

17 Loredo-Abdalá A. La fiebre reu mática. Bol Med Hosp Infant Mex 1983;4:103-108.

18 Gordoresky C, Ulloa S. Escobar-Gutiérrez AJ. HLA: antigens and rheumatic heart disease in Mexico. Rheum 1996; 3 (supl). 112.

19 Patarroyo ME, Winchester RJ, Vejarano A. Association of a B -cell alloantingen with susceptibility to rheumatic fever. Nature 1979;278:173-174.

20 Zabrieskie JB, Lavenchy D, Williams RC. y col. Rheumatic fever- associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum. 1985;28: 1047-1051.

21 Khanna AK, Buskirk DR, Williams RC y col. The presence of a non HLA B-cell antigen in rheumatic fever patients and their families as defines by a monoclonal antibody. J Clin Invest 1989;83:1710-1716.

22 Rodríguez RS, Ontiveros P, To rres S y col. Presencia de un antígenos no HLA en los linfocitos B de pacientes con fiebre reumática y sus familiares definido mediante anticuerpos monoclonales. Bol Med Hosp Infant Mex 1990;47:313-317.

23 Shulman ST. Complications of streptococcal pharyngitis. Pediatr Infect Dis J 1994; 13: S70-S74.

24 Vosti KL. Characterization of a non type specific antigen(s) associated with group A streptococcal type 12 protein. Infect Imm 1975; 11:1300.

25 Krause RM. The streptococcal cell: Relationship of structure to junction and pathogenesis. En: Wannamaker LW, Matsen JM, ed. Streptococci and streptococcal diseases. Recognition, understanding and management. New York: Academic Press Inc,1972:433-450.

26 Mortimer EA Jr, Cushing AH, Jayanetra P, Bunch GP. Studies of streptococcal and staphylococcal L forms in vivo. En: Wannamaker LW, Matsen PM, ed. Streptococci and streptococcal diseases. Recognition, understanding and management. New York: Academic Press, 1992.

27 Markowitz M, Gordis L. Rheumatic fever. Philadelphia: WB Saunders Co., 1972: 42.

28 Potter EU, Svartman M, Mohammed I. Tropical acute rheumatic fever and associated streptococcal infections compared with concurrent acute glomerulonephritis. J Pediatr 1978;92:325-333.

29 Baker CD, Barret FF. Group B streptococcal infections in infants: the importance of the various serotypes. JAMA1974; 230:1158-1160.

30 Siegel JD, McCracken GH Jr, Threlkeld N. Single dose penicilin prophylaxis against neonatal group B streptococcal infections. N Engl J Med 1980;303:769-775.

31 Muldeer CJJ, Zanen HC. Neonatal group B streptococcal meningi tis. Arch Dis Child 1984;59:439-443.

32 Recent advances in rheumatic fever control and future prospects: a WHO Memorandum. Bull WHO 1978;56:887-912.

33 Stollerman GH. Nephritogenic and rheumatogenic group A streptococci. J Infect Dis 1969;120:258-263.

34 Wannammaker LW. Differences between streptococcal infections of the throat and of the skin. N Engl J Med 1970:282:23-31,78 -85.

35 Rotta J, Facklam RR. Manual of microbiological diagnostic methods for streptococcal infections and their sequelae. Ginebra: World Health Organization. 1980,1:3-25.

36 Johnson DR, Stevens D I, Kaplan E L. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infec Dis 1992; 159: 374-382.

37 Stollerman GH. The selective rheumatogeniciti of strains of group A streptococci. Mod Concepts Cardiovascular Disease 1975;44:35.

38 Stevens DI, Tanner M H, Winship J. Severe group A streptococcal infections associated with a toxic-shock syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1-7.

39 Lancefield RC. Current knowledge of type specific M antigens of group A streptococci. J Inmunnol 1962;82:307-313.

40 Kaplan EL, Johnson DR, Cleary PP. Group A streptococcal serotypes insolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid -1980's. J Infect Dis 1989;159:101-103.

41 Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991;325:783-703.

42 Kaplan EL. The group A streptococcal upper respiratory tract carrier state: An enigma. J Pediatr 1980;97:337-345.

43 Kaplan EL. Group A streptococcal carriers and contacts: (When) Is retreatment with antibiotics necessary? En: Stanford ST, ed. Pharingitis management in an era of declining rheumatic fever. New York: Praeger Publishers, 1984163.

44 Clearly PO, Johnson Z. Possible dual function of M protein: Resistance to bacteriophage a 25 and resistance to phagocytosis by human leucocytes. Infect Immun 1977;16:280-292.

45 Fishetti VA. Streptococcal M proteins: Correlation between their immunological cross reactions and structural similarities, with implications for their antiphagocytic action. En: Parker MT, ed. Pathogenic streptococci. Proceeding of the VII the International symposium on streptococci and streptococcal diseases. Surrer: Readbooks Ltd. 1979:17-18.

46 Beachey EH, Ofek L. Epithelial cell binding of group A streptococci by lipoteichoic acid and fimbriae denued of M protein. J Exp Med 1976;143:759-771.

47 Widdowson JP. Immunologic heterogeneity among the M associated protein antigens of group A streptococci. J Med Microbiol 1976;9:73.

48 Rodríguez RS. Glomerulonefritis aguda consecutiva a fiebre escarlatina causada por Streptococcus pyogenes M2/T2. Bol Med Hosp Infant Mex 1968; 25:1069.

49 Giono CS, Avilés EE. Typing of Streptococcus pyogenes isolated from pharingeal swabs in school population from S. Bartolo Naucalpan México. Rev Lat Amer Microbiol 1976;18:65-67.

50 Widdowson JP. The relationship between M antigen and opacity factor in group A Streptococci. J Gener Microb 1971;65:69.

51 El Sadr W, Taranta A. The spectrum and the specter of rheumatic fever in the 1980s. En: Franklin EC. ed. Clinical immunology updat. New York: Elsevier, 1979:183-203.

52 Rodríguez RS. Epidemiología de la glomerulonefritis aguda. Algunas respuestas y nuevos retos. Bol Med Hosp Infant Mex 1981;38:855-864.

53 Robles G, Nava-Zavala A, Reyes AP. Anticuerpos contra productos anticelulares del estreptococo grupo A. Importancia diagnóstica en la fiebre reumática aguda. Arch Inst Cardiol Mex 1995; 65:115-119.

54 Special writing group of the Committe on Rheumatic fever, endocarditis, and Kawasaki Disease of the Council on Cardiovascular disease in the young. American Heart Association guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. Circulation 1993;87:302-307.

55 Sacre HJA, Vázquez AV. Manifes taciones clínicas de faringitis en niños menores de seis meses de edad y su relación con el aislamiento de estreptococcus B hemolyticus. Tesis. Curso de Especialización en Pediatría. UNAM 1985.

56 Espino-Vela J, Rodríguez SR, Cota MTR. Prevalencia del estreptococo beta hemolítico del grupo A en 1574 preescolares de jardines de niños. Act Pediatr Mex 1984;5:18-22.

57 Moreno GB, Bonilla AR, García TR, Román AI. Glomerulonefritis aguda post estreptocócica en niños. Rev Mex Pediatr 1981;68:151-161.

58 Cortazar HP, López Vega ME, González MA. Glomerulonefritis post infecciosa. Estudio longitudinal de 450 casos obser vados en un lapso de 12 años. Bol Med Hosp Infant Mex 1981;38:903.

59 Rammel Kamp C, Denny FY, Wannamaker L. Studies on the epidemiology of rheumatic fever in the Armed Services. En: Rheumatic fever symposium., Minnesota Press, 1952;72:909.

60 García -Casanova C, Loredo- Abdalá A, Carbajal R L. Evalua ción a cinco y diez años de pacientes con fiebre reumática. Acta Pediatr Méx 1983;4:103-108.

61 Loredo Abdalá A, Sierra G-de Quevedo J, Carbajal RL. Fiebre reumática. Perfil clínico de una enfermedad persistente. Gac Med Mex 1991;127:227-231.

62 Kaplan E.L. Acute rheumatic fever Pediatr Clin North Am 1978;25:817-829.

63 Kaplan LE. Epidemilogical approaches to understanding the pathogenesis of rheumatic fever. Internl J Epidemiol 1985;14:499 -501.